It has been reported that the level of miR-154 in GBM is elevated and inversely correlated to the expression of its target phosphoribosyl pyrophosphate synthetase 1 (PRPS1), acting as a positive regulator of proliferation in CD133+ GSCs. Here, PRPS1 is linked to glioblastoma.